Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-013160

Options or other derivatives

  • Chief Financial Officer acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Alam Kamran Chief Financial Officer 2022-02-23 Grant or award · Employee Stock Option (right to buy) +80,000 80,000 D
Loading xslF345X03/doc4.xml…